---
document_datetime: 2023-10-31 11:09:17
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/olumiant-epar-all-authorised-presentations_en.pdf
document_name: olumiant-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.0879011
conversion_datetime: 2025-12-24 21:40:10.974947
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging        | Pack size                  |
|------------------|-------------------|------------|-----------------------|---------------------------|----------------------------|----------------------------|
| EU/1/16/1170/001 | Olumiant          | 2 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 14 tablets                 |
| EU/1/16/1170/002 | Olumiant          | 2 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 28 tablets                 |
| EU/1/16/1170/003 | Olumiant          | 2 mg       | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu)  | 28 x 1 tablets (unit dose) |
| EU/1/16/1170/004 | Olumiant          | 2 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 35 tablets                 |
| EU/1/16/1170/005 | Olumiant          | 2 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 56 tablets                 |
| EU/1/16/1170/006 | Olumiant          | 2 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 84 tablets                 |
| EU/1/16/1170/007 | Olumiant          | 2 mg       | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu)  | 84 x 1 tablets (unit dose) |
| EU/1/16/1170/008 | Olumiant          | 2 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 98 tablets                 |
| EU/1/16/1170/009 | Olumiant          | 4 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 14 tablets                 |
| EU/1/16/1170/010 | Olumiant          | 4 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 28 tablets                 |
| EU/1/16/1170/011 | Olumiant          | 4 mg       | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu)  | 28 x 1 tablets (unit dose) |
| EU/1/16/1170/012 | Olumiant          | 4 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 35 tablets                 |
| EU/1/16/1170/013 | Olumiant          | 4 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 56 tablets                 |
| EU/1/16/1170/014 | Olumiant          | 4 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 84 tablets                 |
| EU/1/16/1170/015 | Olumiant          | 4 mg       | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu)  | 84 x 1 tablets (unit dose) |
| EU/1/16/1170/016 | Olumiant          | 4 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 98 tablets                 |
| EU/1/16/1170/017 | Olumiant          | 1 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 14 tablets                 |
| EU/1/16/1170/018 | Olumiant          | 1 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE/alu) | 28 tablets                 |
| EU/1/16/1170/019 | Olumiant          | 1 mg       | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu)  | 28 x 1 tablets (unit dose) |